BioCentury | Nov 21, 2011
Financial News

Onco-NX completes venture financing

Onco-NX Ltd. , undisclosed location Business: Drug delivery Date completed: 11/10/11 Type: Venture financing Raised: £50,000 ($79,945) Investor: North West Fund for Biomedical WIR Staff...
BioCentury | Nov 21, 2011
Company News

University of Salford drug delivery, cancer news

...The university spun out Onco-NX Ltd. to focus on drug discovery and development of cancer therapeutics. The...
...DT-diaphorase, an enzyme that is overexpressed in many tumors. The compounds are in preclinical testing. Onco-NX...
Items per page:
1 - 2 of 2
BioCentury | Nov 21, 2011
Financial News

Onco-NX completes venture financing

Onco-NX Ltd. , undisclosed location Business: Drug delivery Date completed: 11/10/11 Type: Venture financing Raised: £50,000 ($79,945) Investor: North West Fund for Biomedical WIR Staff...
BioCentury | Nov 21, 2011
Company News

University of Salford drug delivery, cancer news

...The university spun out Onco-NX Ltd. to focus on drug discovery and development of cancer therapeutics. The...
...DT-diaphorase, an enzyme that is overexpressed in many tumors. The compounds are in preclinical testing. Onco-NX...
Items per page:
1 - 2 of 2